Ferndale Pharma Group
MI - FerndaleCDMO (Contract Manufacturing)
Focus: Ferndale Pharma Group is a 126-year-old CDMO specializing in small molecule contract manufacturing for generic drugs. The company operates as a niche manufacturer with highly concentrated revenue dependency on a single therapeutic agent.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Ferndale Pharma Group
AI assessmentNot HiringNo open roles listed right now. Follow Ferndale Pharma Group to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Ferndale Pharma Group's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$234K Part DStable
Pre-Launch
ANDA generic corticosteroid; primary revenue driver (100% of company revenue) but early-stage commercialization suggests adoption or regulatory delays.
Help build intelligence for Ferndale Pharma Group
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.